Skip to main content

Corporate insider profile

Matthew Wein Insider Trades

Latest reported as See Remarks of Metagenomi Therapeutics, Inc. (MGX).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,139.55
Latest transaction
Sep 8, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 8, 2026Metagenomi Therapeutics, Inc. (MGX)See RemarksSale358$1.16$414.71
Jun 5, 2026Metagenomi Therapeutics, Inc. (MGX)See RemarksSale558$1.30$724.84